Lizamarie Bachier

Blood and Marrow Transplant Program

https://www.northside.com/services/research.

Education and Training

Medical School: University of Puerto Rico

Specialty and Certification

Medical Oncology, Hematology

Clinical Trial Cancer Types

Cancer-Related Syndrome, Hodgkin Lymphoma, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes (MDS)

Affiliations

The Blood and Marrow Transplant Group of Georgia Northside Hospital

Active Clinical Trial Sites in Georgia

Northside Hospital Cancer Institute

1000 Johnson Ferry Road NE
Atlanta, GA 30342
404-303-3355 (p)
www.northside.com

driving directions

Clinical Trials

Northside Hospital Cancer Institute - Bone Marrow Transplant (BMT)

1000 Johnson Ferry Road NE
Atlanta, GA 30342
404-851-8523 (p)

driving directions

Clinical Trials
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Cancer Type: Cancer-Related Syndrome

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Cancer Type: Hodgkin Lymphoma

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Cancer Type: Leukemia

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Cancer Type: Lymphoma

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Cancer Type: Multiple Myeloma

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Cancer Type: Myelodysplastic Syndromes (MDS)

Active Clinical Trial Site Locations:

**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.